PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $0.07 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 399 shares traded.
PURE Bioscience Stock Up 12.2%
The firm’s 50-day moving average is $0.07 and its 200-day moving average is $0.07. The company has a market capitalization of $9.10 million, a PE ratio of -2.33 and a beta of 0.27.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. The company’s formulations are designed to provide broad-spectrum antimicrobial activity while supporting applications where effective sanitation and surface treatment are required.
Its product portfolio has included disinfectants, sanitizers and antimicrobial solutions for hard-surface cleaning, food processing, healthcare, hospitality, institutional and commercial environments.
Further Reading
- Five stocks we like better than PURE Bioscience
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
